Seeking Alpha

Bristol Myers Squibb (BMY) and Pfizer (PFE) say the FDA has confirmed the receipt of a New Drug...

Bristol Myers Squibb (BMY) and Pfizer (PFE) say the FDA has confirmed the receipt of a New Drug Application resubmission for Eliquis, a treatment to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs